Oxford Biodyn Share News (OBD)

AIM WINNERS & LOSERS: Norman Broadbent fourth quarter fee income jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

TRADING UPDATES: Mobile Streams sees sales multiply; Corcel gets funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

TRADING UPDATES: Allied Minds eyes delisting; Tertiary completes sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Oxford Biodynamics raises £9.1m in placing

(Sharecast News) - Biotech company Oxford BioDynamics said on Friday that it has conditionally raised around £9.1m in a placing to accelerate the commercialisation of a cancer test.

IN BRIEF: Oxford BioDynamics up on US reimbursement code for EpiSwitch

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers Says its US reimbursement code for EpiSwitch is now available. EpiSwitch Checkpoint-inhibitor Response Test is a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. It was first launched in the US in February.

IN BRIEF: Oxford BioDynamics wins US reimbursement code for EpiSwitch

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Issued a proprietary laboratory code by the American Medical Association's Current Procedural Terminology Editorial Board. The code was issued for the EpiSwitch Checkpoint-inhibitor Response Test, a test which predicts a patient's likely response to immune checkpoint inhibitor therapy.

Oxford BioDynamics shares drop as it might need funding by early 2023

(Alliance News) - Oxford BioDynamics PLC on Tuesday said it will need additional funding - either internal or external - by early 2023, as it posted a sharp drop in half-year revenue, sending its shares tumbling.

UK earnings, trading statements calendar - next 7 days

AIM WINNERS & LOSERS: K3 Capital upbeat; Morses sinks after warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Oxford Biodynamics shares jump as CiRT blood test available in UK

(Alliance News) - Oxford BioDynamics PLC shares rose on Tuesday on news that the biotechnology firm's checkpoint inhibitor response test is now available in the UK.

DIRECTOR DEALINGS: PCA to Bellway chair buys GBP500,000 in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

DIRECTOR DEALINGS: Hyve chair and CEO buy as share price hit by Russia

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Tintra faces sale delay; Seplat makes acquisition

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: